236 related articles for article (PubMed ID: 38096903)
1. Mucosal boosting enhances vaccine protection against SARS-CoV-2 in macaques.
McMahan K; Wegmann F; Aid M; Sciacca M; Liu J; Hachmann NP; Miller J; Jacob-Dolan C; Powers O; Hope D; Wu C; Pereira J; Murdza T; Mazurek CR; Hoyt A; Boon ACM; Davis-Gardner M; Suthar MS; Martinot AJ; Boursiquot M; Cook A; Pessaint L; Lewis MG; Andersen H; Tolboom J; Serroyen J; Solforosi L; Costes LMM; Zahn RC; Barouch DH
Nature; 2024 Feb; 626(7998):385-391. PubMed ID: 38096903
[TBL] [Abstract][Full Text] [Related]
2. An Intranasal OMV-Based Vaccine Induces High Mucosal and Systemic Protecting Immunity Against a SARS-CoV-2 Infection.
van der Ley PA; Zariri A; van Riet E; Oosterhoff D; Kruiswijk CP
Front Immunol; 2021; 12():781280. PubMed ID: 34987509
[TBL] [Abstract][Full Text] [Related]
3. Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques.
Yu J; Tostanoski LH; Mercado NB; McMahan K; Liu J; Jacob-Dolan C; Chandrashekar A; Atyeo C; Martinez DR; Anioke T; Bondzie EA; Chang A; Gardner S; Giffin VM; Hope DL; Nampanya F; Nkolola J; Patel S; Sanborn O; Sellers D; Wan H; Hayes T; Bauer K; Pessaint L; Valentin D; Flinchbaugh Z; Brown R; Cook A; Bueno-Wilkerson D; Teow E; Andersen H; Lewis MG; Martinot AJ; Baric RS; Alter G; Wegmann F; Zahn R; Schuitemaker H; Barouch DH
Nature; 2021 Aug; 596(7872):423-427. PubMed ID: 34161961
[TBL] [Abstract][Full Text] [Related]
4. Intranasal Delivery of MVA Vector Vaccine Induces Effective Pulmonary Immunity Against SARS-CoV-2 in Rodents.
Bošnjak B; Odak I; Barros-Martins J; Sandrock I; Hammerschmidt SI; Permanyer M; Patzer GE; Greorgiev H; Gutierrez Jauregui R; Tscherne A; Schwarz JH; Kalodimou G; Ssebyatika G; Ciurkiewicz M; Willenzon S; Bubke A; Ristenpart J; Ritter C; Tuchel T; Meyer Zu Natrup C; Shin DL; Clever S; Limpinsel L; Baumgärtner W; Krey T; Volz A; Sutter G; Förster R
Front Immunol; 2021; 12():772240. PubMed ID: 34858430
[TBL] [Abstract][Full Text] [Related]
5. Mucosal prime-boost immunization with live murine pneumonia virus-vectored SARS-CoV-2 vaccine is protective in macaques.
Kaiser JA; Nelson CE; Liu X; Park HS; Matsuoka Y; Luongo C; Santos C; Ahlers LRH; Herbert R; Moore IN; Wilder-Kofie T; Moore R; Walker A; Yang L; Munir S; Teng IT; Kwong PD; Dowdell K; Nguyen H; Kim J; Cohen JI; Johnson RF; Garza NL; Via LE; Barber DL; Buchholz UJ; Le Nouën C
Nat Commun; 2024 Apr; 15(1):3553. PubMed ID: 38670948
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 spike-FLIPr fusion protein plus lipidated FLIPr protects against various SARS-CoV-2 variants in hamsters.
Hsieh M-S; Hsu C-W; Liao H-C; Lin C-L; Chiang C-Y; Chen M-Y; Liu S-J; Liao C-L; Chen H-W
J Virol; 2024 Feb; 98(2):e0154623. PubMed ID: 38299865
[TBL] [Abstract][Full Text] [Related]
7. Low-dose Ad26.COV2.S protection against SARS-CoV-2 challenge in rhesus macaques.
He X; Chandrashekar A; Zahn R; Wegmann F; Yu J; Mercado NB; McMahan K; Martinot AJ; Piedra-Mora C; Beecy S; Ducat S; Chamanza R; Huber SR; van Heerden M; van der Fits L; Borducchi EN; Lifton M; Liu J; Nampanya F; Patel S; Peter L; Tostanoski LH; Pessaint L; Van Ry A; Finneyfrock B; Velasco J; Teow E; Brown R; Cook A; Andersen H; Lewis MG; Schuitemaker H; Barouch DH
Cell; 2021 Jun; 184(13):3467-3473.e11. PubMed ID: 34133941
[TBL] [Abstract][Full Text] [Related]
8. Protection against SARS-CoV-2 infection by a mucosal vaccine in rhesus macaques.
Sui Y; Li J; Zhang R; Prabhu SK; Andersen H; Venzon D; Cook A; Brown R; Teow E; Velasco J; Greenhouse J; Putman-Taylor T; Campbell TA; Pessaint L; Moore IN; Lagenaur L; Talton J; Breed MW; Kramer J; Bock KW; Minai M; Nagata BM; Lewis MG; Wang LX; Berzofsky JA
JCI Insight; 2021 Apr; 6(10):. PubMed ID: 33908897
[TBL] [Abstract][Full Text] [Related]
9. Measles Virus-Based Vaccine Expressing Membrane-Anchored Spike of SARS-CoV-2 Inducing Efficacious Systemic and Mucosal Humoral Immunity in Hamsters.
Yang ZH; Song YL; Pei J; Li SZ; Liu RL; Xiong Y; Wu J; Liu YL; Fan HF; Wu JH; Wang ZJ; Guo J; Meng SL; Chen XQ; Lu J; Shen S
Viruses; 2024 Apr; 16(4):. PubMed ID: 38675901
[TBL] [Abstract][Full Text] [Related]
10. Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization.
Lapuente D; Fuchs J; Willar J; Vieira Antão A; Eberlein V; Uhlig N; Issmail L; Schmidt A; Oltmanns F; Peter AS; Mueller-Schmucker S; Irrgang P; Fraedrich K; Cara A; Hoffmann M; Pöhlmann S; Ensser A; Pertl C; Willert T; Thirion C; Grunwald T; Überla K; Tenbusch M
Nat Commun; 2021 Nov; 12(1):6871. PubMed ID: 34836955
[TBL] [Abstract][Full Text] [Related]
11. Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques.
Mercado NB; Zahn R; Wegmann F; Loos C; Chandrashekar A; Yu J; Liu J; Peter L; McMahan K; Tostanoski LH; He X; Martinez DR; Rutten L; Bos R; van Manen D; Vellinga J; Custers J; Langedijk JP; Kwaks T; Bakkers MJG; Zuijdgeest D; Rosendahl Huber SK; Atyeo C; Fischinger S; Burke JS; Feldman J; Hauser BM; Caradonna TM; Bondzie EA; Dagotto G; Gebre MS; Hoffman E; Jacob-Dolan C; Kirilova M; Li Z; Lin Z; Mahrokhian SH; Maxfield LF; Nampanya F; Nityanandam R; Nkolola JP; Patel S; Ventura JD; Verrington K; Wan H; Pessaint L; Van Ry A; Blade K; Strasbaugh A; Cabus M; Brown R; Cook A; Zouantchangadou S; Teow E; Andersen H; Lewis MG; Cai Y; Chen B; Schmidt AG; Reeves RK; Baric RS; Lauffenburger DA; Alter G; Stoffels P; Mammen M; Van Hoof J; Schuitemaker H; Barouch DH
Nature; 2020 Oct; 586(7830):583-588. PubMed ID: 32731257
[TBL] [Abstract][Full Text] [Related]
12. Intranasal administration of unadjuvanted SARS-CoV-2 spike antigen boosts antigen-specific immune responses induced by parenteral protein subunit vaccine prime in mice and hamsters.
Agbayani G; Akache B; Renner TM; Tran A; Stuible M; Dudani R; Harrison BA; Duque D; Bavananthasivam J; Deschatelets L; Hemraz UD; Régnier S; Durocher Y; McCluskie MJ
Eur J Immunol; 2024 Jun; 54(6):e2350620. PubMed ID: 38561974
[TBL] [Abstract][Full Text] [Related]
13. Intranasal inoculation of an MVA-based vaccine induces IgA and protects the respiratory tract of hACE2 mice from SARS-CoV-2 infection.
Americo JL; Cotter CA; Earl PL; Liu R; Moss B
Proc Natl Acad Sci U S A; 2022 Jun; 119(24):e2202069119. PubMed ID: 35679343
[TBL] [Abstract][Full Text] [Related]
14. Neutralizing-antibody-independent SARS-CoV-2 control correlated with intranasal-vaccine-induced CD8
Ishii H; Nomura T; Yamamoto H; Nishizawa M; Thu Hau TT; Harada S; Seki S; Nakamura-Hoshi M; Okazaki M; Daigen S; Kawana-Tachikawa A; Nagata N; Iwata-Yoshikawa N; Shiwa N; Suzuki T; Park ES; Ken M; Onodera T; Takahashi Y; Kusano K; Shimazaki R; Suzaki Y; Ami Y; Matano T
Cell Rep Med; 2022 Feb; 3(2):100520. PubMed ID: 35233545
[TBL] [Abstract][Full Text] [Related]
15. Sex-biased immunogenicity of a mucosal subunit vaccine against SARS-CoV-2 in mice.
Li J; Hsu KS; Howe SE; Hoang T; Xia Z; Berzofsky JA; Sui Y
Front Immunol; 2024; 15():1386243. PubMed ID: 38835757
[TBL] [Abstract][Full Text] [Related]
16. Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates.
Corbett KS; Nason MC; Flach B; Gagne M; O'Connell S; Johnston TS; Shah SN; Edara VV; Floyd K; Lai L; McDanal C; Francica JR; Flynn B; Wu K; Choi A; Koch M; Abiona OM; Werner AP; Moliva JI; Andrew SF; Donaldson MM; Fintzi J; Flebbe DR; Lamb E; Noe AT; Nurmukhambetova ST; Provost SJ; Cook A; Dodson A; Faudree A; Greenhouse J; Kar S; Pessaint L; Porto M; Steingrebe K; Valentin D; Zouantcha S; Bock KW; Minai M; Nagata BM; van de Wetering R; Boyoglu-Barnum S; Leung K; Shi W; Yang ES; Zhang Y; Todd JM; Wang L; Alvarado GS; Andersen H; Foulds KE; Edwards DK; Mascola JR; Moore IN; Lewis MG; Carfi A; Montefiori D; Suthar MS; McDermott A; Roederer M; Sullivan NJ; Douek DC; Graham BS; Seder RA
Science; 2021 Sep; 373(6561):eabj0299. PubMed ID: 34529476
[TBL] [Abstract][Full Text] [Related]
17. Adjuvanting a subunit COVID-19 vaccine to induce protective immunity.
Arunachalam PS; Walls AC; Golden N; Atyeo C; Fischinger S; Li C; Aye P; Navarro MJ; Lai L; Edara VV; Röltgen K; Rogers K; Shirreff L; Ferrell DE; Wrenn S; Pettie D; Kraft JC; Miranda MC; Kepl E; Sydeman C; Brunette N; Murphy M; Fiala B; Carter L; White AG; Trisal M; Hsieh CL; Russell-Lodrigue K; Monjure C; Dufour J; Spencer S; Doyle-Meyers L; Bohm RP; Maness NJ; Roy C; Plante JA; Plante KS; Zhu A; Gorman MJ; Shin S; Shen X; Fontenot J; Gupta S; O'Hagan DT; Van Der Most R; Rappuoli R; Coffman RL; Novack D; McLellan JS; Subramaniam S; Montefiori D; Boyd SD; Flynn JL; Alter G; Villinger F; Kleanthous H; Rappaport J; Suthar MS; King NP; Veesler D; Pulendran B
Nature; 2021 Jun; 594(7862):253-258. PubMed ID: 33873199
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 binding and neutralizing antibody levels after Ad26.COV2.S vaccination predict durable protection in rhesus macaques.
Roozendaal R; Solforosi L; Stieh DJ; Serroyen J; Straetemans R; Dari A; Boulton M; Wegmann F; Rosendahl Huber SK; van der Lubbe JEM; Hendriks J; Le Gars M; Dekking L; Czapska-Casey DN; Guimera N; Janssen S; Tete S; Chandrashekar A; Mercado NB; Yu J; Koudstaal W; Perez-Ruixo JJ; Sadoff J; Barouch DH; Schuitemaker H; Zahn R
Nat Commun; 2021 Oct; 12(1):5877. PubMed ID: 34620860
[TBL] [Abstract][Full Text] [Related]
19. A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.
Pino M; Abid T; Pereira Ribeiro S; Edara VV; Floyd K; Smith JC; Latif MB; Pacheco-Sanchez G; Dutta D; Wang S; Gumber S; Kirejczyk S; Cohen J; Stammen RL; Jean SM; Wood JS; Connor-Stroud F; Pollet J; Chen WH; Wei J; Zhan B; Lee J; Liu Z; Strych U; Shenvi N; Easley K; Weiskopf D; Sette A; Pollara J; Mielke D; Gao H; Eisel N; LaBranche CC; Shen X; Ferrari G; Tomaras GD; Montefiori DC; Sekaly RP; Vanderford TH; Tomai MA; Fox CB; Suthar MS; Kozlowski PA; Hotez PJ; Paiardini M; Bottazzi ME; Kasturi SP
Sci Immunol; 2021 Jul; 6(61):. PubMed ID: 34266981
[TBL] [Abstract][Full Text] [Related]
20. Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primates.
Pillet S; Arunachalam PS; Andreani G; Golden N; Fontenot J; Aye PP; Röltgen K; Lehmicke G; Gobeil P; Dubé C; Trépanier S; Charland N; D'Aoust MA; Russell-Lodrigue K; Monjure C; Blair RV; Boyd SD; Bohm RP; Rappaport J; Villinger F; Landry N; Pulendran B; Ward BJ
Cell Mol Immunol; 2022 Feb; 19(2):222-233. PubMed ID: 34983950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
